Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

Extracorporeal Membrane Oxygenation: Blood Cells

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02748668

Enrollment

371

Registered

2016-04-22

Start date

2015-01-20

Completion date

2023-08-23

Last updated

2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Membrane Oxygenation

Brief summary

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Interventions

OTHERBlood specimen collection

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

ECMO group: Inclusion Criteria: * Greater than or equal to 18 years of age * Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.

Exclusion criteria

* Subject is less than 18 years of age * Known prisoner Control Subjects: Inclusion Criteria * Greater than 18 years of age * Without any known cardiovascular, lung, or autoimmune disease.

Design outcomes

Primary

Measure	Time frame
All cause mortality	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026